Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Ando B. Guindo"'
Autor:
Kavita Gandhi, Mahamadou A Thera, Drissa Coulibaly, Karim Traoré, Ando B Guindo, Amed Ouattara, Shannon Takala-Harrison, Andrea A Berry, Ogobara K Doumbo, Christopher V Plowe
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0148240 (2016)
[This corrects the article DOI: 10.1371/journal.pone.0101783.].
Externí odkaz:
https://doaj.org/article/9a1619d833904334b60346377a96af44
Autor:
Kavita Gandhi, Mahamadou A Thera, Drissa Coulibaly, Karim Traoré, Ando B Guindo, Amed Ouattara, Shannon Takala-Harrison, Andrea A Berry, Ogobara K Doumbo, Christopher V Plowe
Publikováno v:
PLoS ONE, Vol 9, Iss 7, p e101783 (2014)
The malaria vaccine candidate RTS,S/AS01 is based on immunogenic regions of Plasmodium falciparum circumsporozoite protein (CSP) from the 3D7 reference strain and has shown modest efficacy against clinical disease in African children. It remains uncl
Externí odkaz:
https://doaj.org/article/f61a2acb494f4e3ca80d8a8507dec99b
Autor:
Matthew B Laurens, Mahamadou A Thera, Drissa Coulibaly, Amed Ouattara, Abdoulaye K Kone, Ando B Guindo, Karim Traore, Idrissa Traore, Bourema Kouriba, Dapa A Diallo, Issa Diarra, Modibo Daou, Amagana Dolo, Youssouf Tolo, Mahamadou S Sissoko, Amadou Niangaly, Mady Sissoko, Shannon Takala-Harrison, Kirsten E Lyke, Yukun Wu, William C Blackwelder, Olivier Godeaux, Johan Vekemans, Marie-Claude Dubois, W Ripley Ballou, Joe Cohen, Tina Dube, Lorraine Soisson, Carter L Diggs, Brent House, Jason W Bennett, David E Lanar, Sheetij Dutta, D Gray Heppner, Christopher V Plowe, Ogobara K Doumbo
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e79323 (2013)
The FMP2.1/AS02A candidate malaria vaccine was tested in a Phase 2 study in Mali. Based on results from the first eight months of follow-up, the vaccine appeared well-tolerated and immunogenic. It had no significant efficacy based on the primary endp
Externí odkaz:
https://doaj.org/article/f3e7f0ed2aed4ebb916e5715672cdd1e
Autor:
Mahamadou A Thera, Ogobara K Doumbo, Drissa Coulibaly, Matthew B Laurens, Abdoulaye K Kone, Ando B Guindo, Karim Traore, Mady Sissoko, Dapa A Diallo, Issa Diarra, Bourema Kouriba, Modibo Daou, Amagana Dolo, Mounirou Baby, Mahamadou S Sissoko, Issaka Sagara, Amadou Niangaly, Idrissa Traore, Ally Olotu, Olivier Godeaux, Amanda Leach, Marie-Claude Dubois, W Ripley Ballou, Joe Cohen, Darby Thompson, Tina Dube, Lorraine Soisson, Carter L Diggs, Shannon L Takala, Kirsten E Lyke, Brent House, David E Lanar, Sheetij Dutta, D Gray Heppner, Christopher V Plowe
Publikováno v:
PLoS ONE, Vol 5, Iss 2, p e9041 (2010)
The objective was to evaluate the safety and immunogenicity of the AMA1-based malaria vaccine FMP2.1/AS02(A) in children exposed to seasonal falciparum malaria.A Phase 1 double blind randomized controlled dose escalation trial was conducted in Bandia
Externí odkaz:
https://doaj.org/article/cc6d77a455c44be3828ff996e6e1400d
Autor:
Mahamadou A Thera, Ogobara K Doumbo, Drissa Coulibaly, Dapa A Diallo, Abdoulaye K Kone, Ando B Guindo, Karim Traore, Alassane Dicko, Issaka Sagara, Mahamadou S Sissoko, Mounirou Baby, Mady Sissoko, Issa Diarra, Amadou Niangaly, Amagana Dolo, Modibo Daou, Sory I Diawara, D Gray Heppner, V Ann Stewart, Evelina Angov, Elke S Bergmann-Leitner, David E Lanar, Sheetij Dutta, Lorraine Soisson, Carter L Diggs, Amanda Leach, Alex Owusu, Marie-Claude Dubois, Joe Cohen, Jason N Nixon, Aric Gregson, Shannon L Takala, Kirsten E Lyke, Christopher V Plowe
Publikováno v:
PLoS ONE, Vol 3, Iss 1, p e1465 (2008)
The objective was to evaluate the safety, reactogenicity and immunogenicity of the AMA-1-based blood-stage malaria vaccine FMP2.1/AS02A in adults exposed to seasonal malaria.A phase 1 double blind randomized controlled dose escalation trial was condu
Externí odkaz:
https://doaj.org/article/15ab68b51b8a4e868fb076837e1ef8a9
Autor:
Shannon L Takala, Drissa Coulibaly, Mahamadou A Thera, Alassane Dicko, David L Smith, Ando B Guindo, Abdoulaye K Kone, Karim Traore, Amed Ouattara, Abdoulaye A Djimde, Paul S Sehdev, Kirsten E Lyke, Dapa A Diallo, Ogobara K Doumbo, Christopher V Plowe
Publikováno v:
PLoS Medicine, Vol 4, Iss 3, p e93 (2007)
BackgroundMalaria vaccines based on the 19-kDa region of merozoite surface protein 1 (MSP-1(19)) derived from the 3D7 strain of Plasmodium falciparum are being tested in clinical trials in Africa. Knowledge of the distribution and natural dynamics of
Externí odkaz:
https://doaj.org/article/4c0a90fa140c4e70b74d2176f352cd98
Autor:
Bart W. Faber, Karim Traore, Odile Leroy, Abdourhamane H. Sall, Roma Chilengi, Sanie S. S. Sesay, Issa Diarra, Modibo Daou, Clemens H. M. Kocken, Drissa Coulibaly, Amadou Niangaly, Mahamadou A. Thera, Alan W. Thomas, Youssouf Tolo, M. Baby, Charles Arama, Mahamadou S Sissoko, Issaka Sagara, Egeruan B. Imoukhuede, Idrissa M. Traore, Abdoulaye K. Kone, Bourema Kouriba, Dapa A. Diallo, Ando B. Guindo, Edmond J. Remarque, Mady Sissoko, Ogobara K. Doumbo, Amagana Dolo, Ramadhani A. Noor, Ousmane B. Toure
Publikováno v:
Malaria Journal
Background The safety and immunogenicity of PfAMA1, adjuvanted with Alhydrogel® was assessed in malaria–experienced Malian adults. The malaria vaccine, PfAMA1-FVO [25-545] is a recombinant protein Pichia pastoris-expressed AMA-1 from Plasmodium fa
Autor:
Laura Burdett, Angela Wahl, Robert J. Hartzman, Abdoulaye K. Kone, William H. Hildebrand, Marcelo A. Fernández-Viňa, Ando B. Guindo, Drissa Coulibaly, Christopher V. Plowe, K. Cao, Ogobara K. Doumbo, Marcelo B. Sztein, Kirsten E. Lyke, Jill A. Hollenbach
Publikováno v:
Tissue Antigens
Pre-erythrocytic immunity to Plasmodium falciparum malaria is likely to be mediated by T-cell recognition of malaria epitopes presented on infected host cells via class I and II major histocompatibility complex (MHC) antigens. To test for association
Autor:
Issa Diarra, Yacouba Cissoko, Christopher V. Plowe, D. Channe Gowda, Modibo Daou, Gowdahalli Krishnegowda, Ando B. Guindo, Karim Traore, Abdoulaye K. Kone, Kirsten E. Lyke, Alassane Dicko, Dapa A. Diallo, Ogobara K. Doumbo, Marcelo B. Sztein
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 75:199-204
Neutralizing antibodies to glycosylphosphatidylinositols (GPIs), which are Plasmodium falciparum surface protein anchor molecules implicated in malaria pathogenesis, are thought to protect against symptomatic malaria. Index cases of severe malaria in
Autor:
Karim Traore, Kirsten E. Lyke, Alassane Dicko, Abdoulaye K. Kone, Ogobara K. Doumbo, Marcelo B. Sztein, Abdoulaye Dabo, Drissa Coulibaly, Lansana Sangaré, Issa Diarra, Christopher V. Plowe, Modibo Daou, Ando B. Guindo
Publikováno v:
The American Journal of Tropical Medicine and Hygiene. 73:1124-1130
Plasmodium falciparum and Schistosoma haematobium are co-endemic parasitic diseases with worldwide distribution. Evidence suggests interactions occur between helminthic and malaria infections, although it is unclear whether this effect is beneficial